News
Deepslate raises €7.7M seed for European speech-to-speech AI
Berlin's Deepslate raised a €7.7M seed led by 42CAP to train Opal, a speech-to-speech AI model for European languages, hosted on EU infrastructure at €0.02 a minute.
Osavul raises €8.5M Series A for hybrid threat intelligence
Ukrainian-founded, Luxembourg-based Osavul has raised €8.5M from 33N Ventures, Balnord, G+D Ventures and 42CAP after quadrupling contract value in 2025. Next stop: enterprise.
Mallow raises €11M seed for screen-free AI play
Cédric O's Mallow raised €11M from General Catalyst and Balderton two years before anyone saw the product - a Paris bet that the $1.43bn kids audio market is ready for…
Trustly secures $40M from Nordic Capital for AI payments push
Three weeks after cutting a quarter of its staff, Trustly's own shareholders committed more than $40M to turn its $120bn payments network into an AI business intelligence engine.
Inovus Medical raises £15M growth round for surgical simulators
A St Helens medtech that trains surgeons on hydrogel organs has landed around £15M from PXN Ventures, Mercia, Hayfin and Texas-based Unorthodox Ventures, most of it pointed at US residency…
Inbolt raises €11M to scale vision-guided factory robots
Shift4Good leads an €11M round in Inbolt, whose 3D vision already guides 200+ robots in 100+ factories for Toyota, Ford and Stellantis - next stops the US, APAC and data…
Foundational raises £8.2M pre-seed for satellite laser ranging
The London startup leaves stealth with £8.2 million, the largest pre-seed any European space tech company has raised, to turn satellite laser ranging into a commercial service.
Metaview raises $60M Series C for agentic recruiting
Metaview's $60M Series C, led by Insight Partners, takes the London agentic recruiting company to $110M raised and puts an autonomous AI recruiter in front of its 7,000 customers.
Restate raises $20M Series A to make AI agents crash-proof
Apache Flink co-creator Stephan Ewen has raised again: Paris fund Singular leads a $20M Series A into Berlin's Restate, with Redpoint and Capital One Ventures, to make crash-proof AI agents…
Breye Therapeutics raises €67.5M Series A for oral eye drug
Hørsholm's Breye Therapeutics closed an over-subscribed €67.5M Series A to swap eye injections for a pill in early diabetic retinopathy, with a Phase 2 trial set for 2027.